To summarize, the data from ACT experiments show that CD4+ T cells can mediate direct tumor killing of MHC-II-expressing tumors and indirect killing of MHC-II-negative tumors, possibly by their activation of macrophages in the TME, which can then mediate killing that is not restricted by tumor expression of MHC I or II. The gene discussed is CD4; the disease is neoplasm.